J
Jeongwoo Kim
Researcher at Yonsei University
Publications - 20
Citations - 95
Jeongwoo Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Gene regulatory network & Gene. The author has an hindex of 5, co-authored 18 publications receiving 66 citations.
Papers
More filters
Journal ArticleDOI
ADC: Advanced document clustering using contextualized representations
TL;DR: A conceptually simple but experimentally effective clustering framework called Advanced Document Clustering (ADC), which can take advantages of contextualized representations while mitigating the limitations introduced by high-dimensional vectors.
Journal ArticleDOI
LGscore: A method to identify disease-related genes using biological literature and Google data.
TL;DR: A method called LGscore, which identifies disease-related genes using Google data and literature data as well as candidate genes for Alzheimer's disease, diabetes, colon cancer, lung cancer, and prostate cancer, was up to 40% more accurate than existing methods.
Journal ArticleDOI
Machine learning-based identification of genetic interactions from heterogeneous gene expression profiles.
TL;DR: A random forest-based method to classify significant GGIs from gene expression data using Alzheimer's disease data showed remarkable accuracy, and the GGIs established in the analysis can be used to build a meaningful genetic network that can explain the mechanisms underlying Alzheimer’s disease.
Journal ArticleDOI
IMA: Identifying disease-related genes using MeSH terms and association rules.
TL;DR: A method to identify disease-related genes using MeSH terms and association rules is proposed and 34 important candidate genes are presented with evidence that supports the relationship of the candidate genes with diseases.
Proceedings ArticleDOI
CSnet: Constructing symptom network based on disease-symptom relationships
TL;DR: This paper attempts to expand and build on previous studies by introducing a network-based symptom analysis and has shown possibility for a guideline of clinical demonstration and a discovery of potential symptoms pair.